While gene set enrichment analysis (GSEA) [31] of the PH and Fibrosis Networks predictably identified pathways involved in fibrosis and vascular stiffness (i.e., TGF-β/BMP signaling among others), GSEA of the non-PH/non-fibrosis genes indicated a number of novel pathways, such as immune activation, cell cycle checkpoint regulation, and DNA damage [32,33], never associated with miR-130/301, vascular stiffening, or several of these factors of hereditary PAH (Figure 5B, Tables S2 and S3). The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.